SCHEMBL31748608

SCHEMBL31748608

COc1ccccc1C(=O)Nc1ccc2nc(-c3ccc(F)cc3)[nH]c2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR2E3 Q9Y5X4 11/20 0.63
▸ MAPT P10636 3/20 0.61
▸ KDM4E B2RXH2 2/20 0.61
▸ ALDH1A1 P00352 2/20 0.61
▸ HPGD P15428 2/20 0.61
▸ NPC1 O15118 1/20 0.61
▸ RAB9A P51151 1/20 0.61
▸ HSD17B10 Q99714 1/20 0.61
▸ CHEK2 O96017 1/20 0.57
▸ KMT2A Q03164 3/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ MMP2 P08253 1/20 0.56
▸ MMP9 P14780 1/20 0.56
▸ MMP8 P22894 1/20 0.56
▸ MMP13 P45452 1/20 0.56
▸ MEN1 O00255 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ GAA P10253 1/20 0.55
▸ MAPK1 P28482 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26597196 1.00 NR2E3 (0.63) NR2E3MAPTKDM4EALDH1A1HPGD
SCHEMBL26597175 0.91 NR2E3 (0.62) NR2E3MAPTKDM4EALDH1A1HPGD
SCHEMBL31748600 0.91 NR2E3 (0.62) NR2E3MAPTKDM4EALDH1A1HPGD
SCHEMBL30667676 0.90 NR2E3 (0.58) NR2E3MAPTKDM4EALDH1A1HPGD
SCHEMBL31748729 0.90 NR2E3 (0.58) NR2E3MAPTKDM4EALDH1A1HPGD
SCHEMBL26597202 0.90 NR2E3 (0.58) NR2E3MAPTKDM4EALDH1A1HPGD
SCHEMBL31748782 0.87 NR2E3 (0.57) NR2E3MAPTKDM4EALDH1A1HPGD
SCHEMBL26597190 0.87 NR2E3 (0.57) NR2E3MAPTKDM4EALDH1A1HPGD
SCHEMBL30667669 0.86 KMT2A (0.62) NR2E3MAPTKDM4EALDH1A1HPGD
SCHEMBL26597191 0.86 KMT2A (0.62) NR2E3MAPTKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388551-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS UNIV PARIS CITE (FR) 2025-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388551-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS CXCL10, CCR10, IL2 NR2E3 2814/4885MAPT 4593/4885KDM4E 3301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback